Information about APG Private Equity Fund 2018-2019 GP
My details
*
*
*
No warnings for this company
{{translate('company_activity_bron_' + bron)}}
Code Description
{{activiteit.code}} {{activiteit.description}}

APG Private Equity Fund 2018-2019 GP (SRL)

Company information

Status
Active

KVK number

70133913

VAT Number

Established
21-11-2017
Last balance sheet year
2023
Company size
Micro 0 FTE
RSIN number
858156817
Principal activity
Activiteiten van financieringsentiteiten binnen concernverband
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from APG Private Equity Fund 2018-2019 GP

2023 2022 2021 2020
Equity USD 8.598 188 % USD -9.757 -226 % USD 7.755 -22 % USD 9.978
Employees 0 0 0 0

Frequently asked questions

What is the VAT number of APG Private Equity Fund 2018-2019 GP?
Log in or start a free trial to view the VAT number.
What is the KVK number of APG Private Equity Fund 2018-2019 GP?
The KVK number of APG Private Equity Fund 2018-2019 GP is 70133913
When was APG Private Equity Fund 2018-2019 GP founded?
APG Private Equity Fund 2018-2019 GP was founded on 21-11-2017.
What is the address of APG Private Equity Fund 2018-2019 GP?
The current registered office of APG Private Equity Fund 2018-2019 GP is located at Oude Lindestraat 70, 6411 EJ Heerlen.
When was the last time APG Private Equity Fund 2018-2019 GP filed their annual financial statements?
The most recent financial statements of APG Private Equity Fund 2018-2019 GP were filed on 14-11-2024.
How many employees does APG Private Equity Fund 2018-2019 GP have?
There are currently no employees working at APG Private Equity Fund 2018-2019 GP or no workforce information is available.
What is the annual turnover of APG Private Equity Fund 2018-2019 GP?
There is no turnover available for APG Private Equity Fund 2018-2019 GP.